Zobrazeno 1 - 10
of 32
pro vyhledávání: '"MESH: Amides"'
Autor:
Fran Robson, Palma Rocchi, Sinem Demirbag, Thi Khanh Le, Khadija Shahed Khan, Clément Paris, Peter Barfuss, Wai-Lung Ng
Publikováno v:
Molecular Cell
Molecular Cell, Elsevier, 2020, 79 (5), pp.710-727. ⟨10.1016/j.molcel.2020.07.027⟩
Molecular Cell, 2020, 79 (5), pp.710-727. ⟨10.1016/j.molcel.2020.07.027⟩
Molecular Cell, Elsevier, 2020, 79 (5), pp.710-727. ⟨10.1016/j.molcel.2020.07.027⟩
Molecular Cell, 2020, 79 (5), pp.710-727. ⟨10.1016/j.molcel.2020.07.027⟩
Summary The coronavirus disease 2019 (COVID-19) that is wreaking havoc on global public health and economies has heightened awareness about the lack of effective antiviral treatments for human coronaviruses (CoVs). Many current antivirals, notably nu
Publikováno v:
Clinical Nuclear Medicine
Clinical Nuclear Medicine, Lippincott, Williams & Wilkins, 2020, 45 (2), pp.133-135. ⟨10.1097/RLU.0000000000002861⟩
Clinical Nuclear Medicine, Lippincott, Williams & Wilkins, 2020, 45 (2), pp.133-135. ⟨10.1097/RLU.0000000000002861⟩
International audience; There is a growing interest in assessment of future remnant liver function with Tc-mebrofenin hepatobiliary scintigraphy before major hepatectomy to estimate the risk of posthepatectomy liver failure. We illustrate the case of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bebe2ff94a4c28fbeced4709ba214ff
https://hal.umontpellier.fr/hal-03384686
https://hal.umontpellier.fr/hal-03384686
Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes
Autor:
Xavier Brazzolotto, Florian Nachon, Marko Živin, Jure Stojan, Maja Zorović, Damijan Knez, Jacques-Philippe Colletier, Urban Košak, Stanislav Gobec, Stane Pajk, Nicolas Coquelle
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry, 2020, 35 (1), pp.498-505. ⟨10.1080/14756366.2019.1710502⟩
Journal of Enzyme Inhibition and Medicinal Chemistry, Informa Healthcare, 2020, 35 (1), pp.498-505. ⟨10.1080/14756366.2019.1710502⟩
Journal of enzyme inhibition and medicinal chemistry, vol. 35, no. 1, pp. 498-505, 2020.
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 35, Iss 1, Pp 498-505 (2020)
Journal of Enzyme Inhibition and Medicinal Chemistry, 2020, 35 (1), pp.498-505. ⟨10.1080/14756366.2019.1710502⟩
Journal of Enzyme Inhibition and Medicinal Chemistry, Informa Healthcare, 2020, 35 (1), pp.498-505. ⟨10.1080/14756366.2019.1710502⟩
Journal of enzyme inhibition and medicinal chemistry, vol. 35, no. 1, pp. 498-505, 2020.
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 35, Iss 1, Pp 498-505 (2020)
International audience; Brain butyrylcholinesterase (BChE) is an attractive target for drugs designed for the treatment of Alzheimer’s disease (AD) in its advanced stages. It also potentially represents a biomarker for progression of this disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::346bbfead7d353e2e74735bc335c4593
https://hal.science/hal-03014299/file/Pajk2020.pdf
https://hal.science/hal-03014299/file/Pajk2020.pdf
Autor:
Madelain, Vincent, Baize, Sylvain, Jacquot, Frédéric, Reynard, Stéphanie, Fizet, Alexandra, Barron, Stephane, Solas, Caroline, Lacarelle, Bruno, Carbonnelle, Caroline, Mentré, France, Raoul, Hervé, de Lamballerie, Xavier, Guedj, Jérémie
Publikováno v:
Nature Communications
Nature Communications, 2018, 9 (1), pp.4013. ⟨10.1038/s41467-018-06215-z⟩
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Nature Communications, Nature Publishing Group, 2018, 9, ⟨10.1038/s41467-018-06215-z⟩
Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.4013. ⟨10.1038/s41467-018-06215-z⟩
Nature Communications, 2018, 9 (1), pp.4013. ⟨10.1038/s41467-018-06215-z⟩
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Nature Communications, Nature Publishing Group, 2018, 9, ⟨10.1038/s41467-018-06215-z⟩
Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.4013. ⟨10.1038/s41467-018-06215-z⟩
Despite several clinical trials implemented, no antiviral drug could demonstrate efficacy against Ebola virus. In non-human primates, early initiation of polymerase inhibitors favipiravir and remdesivir improves survival, but whether they could be ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d154ac0e471157d76dc4db477c6eb882
https://hal-pasteur.archives-ouvertes.fr/pasteur-03236192/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-03236192/document
Autor:
Maximilian J. Helf, James Sims, Jörn Piel, Brandon I. Morinaka, Anna L. Vagstad, Muriel Gugger, Shinichi Sunagawa, Marjan Verest, Edgars Lakis, Thibault Scalvenzi
Publikováno v:
Science
Science, 2018, 359 (6377), pp.779-782. ⟨10.1126/science.aao0157⟩
Science, American Association for the Advancement of Science, 2018, 359 (6377), pp.779-782. ⟨10.1126/science.aao0157⟩
Science, 2018, 359 (6377), pp.779-782. ⟨10.1126/science.aao0157⟩
Science, American Association for the Advancement of Science, 2018, 359 (6377), pp.779-782. ⟨10.1126/science.aao0157⟩
Protein backbone, broken and mended Small, posttranslationally modified peptides are produced by microorganisms as antimicrobial agents or to communicate with neighboring cells. Alterations to the peptide backbone can change the structure of peptides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a6a19830fe9433d8efaa92f9373eb42
https://hal-pasteur.archives-ouvertes.fr/pasteur-02044549
https://hal-pasteur.archives-ouvertes.fr/pasteur-02044549
Autor:
Mathy Froeyen, Leen Delang, Stéphanie Beaucourt, Bruno Canard, Ana Theresa Silveira de Morais, Isabelle Imbert, Johan Neyts, Marco Vignuzzi, Hervé Blanc, Pieter Leyssen, Rana Abdelnabi
Publikováno v:
Journal of Virology
Journal of Virology, 2017, 91 (12), pp.e00487-17. ⟨10.1128/JVI.00487-17⟩
Journal of Virology, American Society for Microbiology, 2017, 91 (12), pp.e00487-17. ⟨10.1128/JVI.00487-17⟩
Journal of Virology, 2017, 91 (12), pp.e00487-17. ⟨10.1128/JVI.00487-17⟩
Journal of Virology, American Society for Microbiology, 2017, 91 (12), pp.e00487-17. ⟨10.1128/JVI.00487-17⟩
Favipiravir (T-705) is a broad-spectrum antiviral agent that has been approved in Japan for the treatment of influenza virus infections. T-705 also inhibits the replication of various RNA viruses, including chikungunya virus (CHIKV). We demonstrated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ec8ca79e6936169943b98e6fae68ff
https://hal-pasteur.archives-ouvertes.fr/pasteur-02545928
https://hal-pasteur.archives-ouvertes.fr/pasteur-02545928
Autor:
Nguyen, Thi Huyen Tram, Guedj, Jérémie, Anglaret, Xavier, Laouénan, Cédric, Madelain, Vincent, Taburet, Anne-Marie, Baize, Sylvain, Sissoko, Daouda, Pastorino, Boris, Rodallec, Anne, Piorkowski, Géraldine, Carazo, Sara, Conde, Mamoudou N, Gala, Jean-Luc, Bore, Joseph Akoi, Carbonnelle, Caroline, Jacquot, Frédéric, Raoul, Hervé, Malvy, Denis, de Lamballerie, Xavier, Mentré, France, JIKI study group
Publikováno v:
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Public Library of Science, 2017, 11 (2), pp.e0005389. ⟨10.1371/journal.pntd.0005389⟩
PLoS Neglected Tropical Diseases, Vol 11, Iss 2, p e0005389 (2017)
PLOS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, 2017, 11 (2), pp.e0005389. ⟨10.1371/journal.pntd.0005389⟩
PLoS Neglected Tropical Diseases, Vol. 11, no.2, p. e0005389 [1-18] (2017)
PLoS Neglected Tropical Diseases, Public Library of Science, 2017, 11 (2), pp.e0005389. ⟨10.1371/journal.pntd.0005389⟩
PLoS Neglected Tropical Diseases, Vol 11, Iss 2, p e0005389 (2017)
PLOS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, 2017, 11 (2), pp.e0005389. ⟨10.1371/journal.pntd.0005389⟩
PLoS Neglected Tropical Diseases, Vol. 11, no.2, p. e0005389 [1-18] (2017)
Background In 2014–2015, we assessed favipiravir tolerance and efficacy in patients with Ebola virus (EBOV) disease (EVD) in Guinea (JIKI trial). Because the drug had never been used before for this indication and that high concentrations of the dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1051530eae51cb41207f0c146dd54e76
https://hal.archives-ouvertes.fr/hal-02309055
https://hal.archives-ouvertes.fr/hal-02309055
Publikováno v:
Organic and Biomolecular Chemistry
Organic and Biomolecular Chemistry, Royal Society of Chemistry, 2012, 10 (1), pp.126-33. ⟨10.1039/c1ob06567j⟩
Organic and Biomolecular Chemistry, Royal Society of Chemistry, 2012, 10 (1), pp.126-33. ⟨10.1039/c1ob06567j⟩
International audience; The investigation into the luminescence properties of a lanthanide-binding peptide, derived from the Ca-binding loop of the parvalbumin, and modified by incorporating a 1,8-naphthalimide (Naph) chromophore at the N-terminus is
Autor:
Maté Biro, Annelie Oswald, Guillaume Salbreux, Jakub Sedzinski, Ewa K. Paluch, Jean-Yves Tinevez
Publikováno v:
Nature
Nature, Nature Publishing Group, 2011, 476 (7361), pp.462-466. ⟨10.1038/nature10286⟩
Nature, Nature Publishing Group, 2011, 476 (7361), pp.462-466. ⟨10.1038/nature10286⟩
Studies of the mechanism of cytokinesis, the process by which a mother cell undergoes cleavage to form two separated daughter cells, often focus on the action of the contractile actomyosin ring at the cell equator. Ewa Paluch and colleagues instead i
Autor:
David Bec, Jean-Yves Bansard, Patrick Guinet, Pascal Lecorre, Eric Wodey, Jean-Pierre Estebe, Maja Ratajczak-Enselme, François Chevanne, Claude Ecoffey
Publikováno v:
Regional Anesthesia and Pain Medicine
Regional Anesthesia and Pain Medicine, Lippincott, Williams & Wilkins, 2009, 34 (1), pp.17-23. ⟨10.1097/AAP.0b013e31819338e2⟩
Regional Anesthesia and Pain Medicine, 2009, 34 (1), pp.17-23. ⟨10.1097/AAP.0b013e31819338e2⟩
Regional Anesthesia and Pain Medicine, Lippincott, Williams & Wilkins, 2009, 34 (1), pp.17-23. ⟨10.1097/AAP.0b013e31819338e2⟩
Regional Anesthesia and Pain Medicine, 2009, 34 (1), pp.17-23. ⟨10.1097/AAP.0b013e31819338e2⟩
International audience; BACKGROUND AND OBJECTIVES: Neural blockade techniques are associated with a risk of acute cardiac toxicity after accidental intravenous (IV) injection of local anesthetics. The aim of this study was to compare electrocardiogra